Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · Real-Time Price · USD
1.900
-0.220 (-10.38%)
At close: Jul 24, 2025, 4:00 PM
1.934
+0.034 (1.79%)
After-hours: Jul 24, 2025, 7:34 PM EDT
Company Description
Intelligent Bio Solutions Inc., a medical technology company, developing rapid, non-invasive testing, and screening solutions.
The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse.
It also operates biosensor platform for clinical chemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.
The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022.
Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York. The company operates as a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
Intelligent Bio Solutions Inc.
| Country | United States |
| Founded | 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 50 |
| CEO | Harry Simeonidis |
Contact Details
Address: 135 West, 41ST Street, 5th Floor New York, New York 10036 United States | |
| Phone | 646 828 8258 |
| Website | ibs.inc |
Stock Details
| Ticker Symbol | INBS |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001725430 |
| CUSIP Number | 36151G600 |
| ISIN Number | US36151G6008 |
| Employer ID | 82-1512711 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Harry Simeonidis | President and Chief Executive Officer |
| Spiro Kevin Sakiris B.Bus, C.A., CA, Dip Law | Chief Financial Officer |
| Callistus Sequeira | Vice President of Global Quality and Operations |
| Doug Heath | Vice President of Global Sales |
| Anna Turkington | Vice President of Marketing |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jul 23, 2025 | 8-K | Current Report |
| Jul 16, 2025 | 8-K | Current Report |
| Jul 15, 2025 | 8-K | Current Report |
| Jul 3, 2025 | 8-K | Current Report |
| May 30, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 16, 2025 | 8-K | Current Report |
| May 13, 2025 | 8-K | Current Report |
| May 13, 2025 | 10-Q | Quarterly Report |
| Apr 29, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 28, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |